Tyson 2.0 cannabis products mock up. (Source: Google Gemini. Generated by AI)
  • TerrAscend (TSX:TSND) signed an exclusive licensing agreement with Tyson 2.0, legendary boxer Mike Tyson’s cannabis brand, to launch its product portfolio in Maryland and Pennsylvania beginning in 2026
  • TerrAscend is a vertically integrated cannabis company with interests across North America
  • The cannabis stock has given back 45.05 per cent year-over-year and 73.48 per cent since 2020

TerrAscend (TSX:TSND), a top North American cannabis company, signed an exclusive licensing agreement with Tyson 2.0, legendary boxer Mike Tyson’s cannabis brand, to launch its product portfolio in Maryland and Pennsylvania beginning in 2026.

TerrAscend will manufacture and distribute flower, vapes and edibles in Maryland, while offering flower, vapes, concentrates and troches through its Apothecarium dispensaries and wholesale network in Pennsylvania.

The news follows TerrAscend’s standout results for Q3 2025, marked by stable revenue of US$65.1 million and free cash flow of US$4.9 million, representing its 9th consecutive quarter posting a positive figure under the metric.

Management commentary

“Cannabis changed my life and I want to share that with the world,” Mike Tyson, co-founder of Tyson 2.0, said in Tuesday’s news release. “Partnering with TerrAscend lets us reach more people and deliver products we’re proud of in Maryland and Pennsylvania.”

“Thank you, Mike, for your hard work and commitment to advancing the cannabis industry and federal reform,” added Jason Wild, executive chairman of TerrAscend. “I’ve seen firsthand that when you commit to something, you give it everything you’ve got. TerrAscend is proud to partner with Tyson 2.0 and bring that same dedication and energy to Maryland and Pennsylvania.”

About TerrAscend

TerrAscend is a vertically integrated cannabis company with interests across North America, including operations in Pennsylvania, New Jersey, Maryland, Ohio, California and Canada. The company’s owned or licensed brand portfolio includes The Apothecarium, Cookies, Lemonnade, Ilera Healthcare, Kind Tree, Legend, State Flower, Wana and Valhalla Confections. 

TerrAscend stock (TSX:TSND) last traded at C$0.61. The stock has given back 45.05 per cent year-over-year and 73.48 per cent since 2020.

Join the discussion: Find out what investors are saying about this cannabis stock on the TerrAscend Corp. Bullboard and make sure to explore the rest of Stockhouse’s stock forums and message boards.

Stockhouse does not provide investment advice or recommendations. All investment decisions should be made based on your own research and consultation with a registered investment professional. The issuer is solely responsible for the accuracy of the information contained herein.

For full disclaimer information, please click here.


More From The Market Online
AI generated stock image

@ the Bell: Sagging commodities weigh on TSX

Commodity prices fell on Thursday, weighing heavily on the resource-focused TSX. Meanwhile, the US House of...

Market Open: Bombardier Lifts Q4 Results, SoftBank Swings Back to Profit | Feb 12th

TSX opens mixed as Bombardier posts stronger Q4 results and SoftBank returns to profit. Gold and oil slip, Bitcoin rises, and markets digest strong…

Manulife Q4 profit slips while Sun Life posts double‑digit earnings growth

Manulife (TSX:MFC) and Sun Life (TSX:SLF) boosted shareholder returns, but Sun Life enters 2026 with stronger earnings momentum.

Solar stock Enphase Energy is priced to shine

My due diligence on Enphase Energy, a mid-cap stock tracking the world's largest provider of microinverter-based solar and battery systems.